|
1
|
Huang H, Liu YX, Zhan ZL, Liang H, Wang P
and Ren XB: Different sites and prognoses of gastrointestinal
stromal tumors of the stomach: Report of 187 cases. World J Surg.
34:1523–1533. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tran T, Davila JA and El-Serag HB: The
epidemiology of malignant gastrointestinal stromal tumors: An
analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol.
100:162–168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Doğusoy G Bülbül: Turkish GIST Working
Group: Gastrointestinal stromal tumors: A multicenter study of 1160
Turkish cases. Turk J Gastroenterol. 23:203–211. 2012.PubMed/NCBI
|
|
4
|
von Mehren M, Randall RL, Benjamin RS,
Boles S, Bui MM, Casper ES, Conrad EU III, DeLaney TF, Ganjoo KN,
George S, et al: Gastrointestinal stromal tumors, version 2.2014. J
Natl Compr Canc Netw. 12:853–862. 2014.PubMed/NCBI
|
|
5
|
Joensuu H, Eriksson M, Hall KS, Hartmann
JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J,
Al-Batran SE, et al: Risk factors for gastrointestinal stromal
tumor recurrence in patients treated with adjuvant imatinib.
Cancer. 120:2325–2333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen C, Chen H, Yin Y and Chen J, Zhang B,
Chen Z and Chen J: Preoperative imatinib for patients with primary
unresectable or metastatic/recurrent gastrointestinal stromal
tumor. Clinics (Sao Paulo). 69:758–762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bischof DA, Kim Y, Blazer DG III, Behman
R, Karanicolas PJ, Law CH, Quereshy FA, Maithel SK, Gamblin TC,
Bauer TW, et al: Surgical management of advanced gastrointestinal
stromal tumors: An international multi-institutional analysis of
158 patients. J Am Coll Surg. 219:439–449. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ogata K, Mochiki E, Ojima H, Haga N,
Fukuchi M, Aihara R, Ando H, Uchida N, Toyomasu Y, Suzuki M, et al:
A multicenter long-term study of imatinib treatment for Japanese
patients with unresectable or recurrent gastrointestinal stromal
tumors. J Surg Oncol. 110:942–946. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao X, Xue A, Fang Y, Shu P, Ling J, Hu J,
Hou Y, Shen K, Qin J, Sun Y, et al: Clinicopathological features of
small gastrointestinal stromal tumors. Zhonghua Wei Chang Wai Ke Za
Zhi. 18:338–341. 2015.(In Chinese). PubMed/NCBI
|
|
10
|
Sorour MA, Kassem MI, Ghazal A-H,
El-Riwini MT and Abu Nasr A: Gastrointestinal stromal tumors (GIST)
related emergencies. Int J Surg. 12:269–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawanowa K, Sakuma Y, Sakurai S, Hishima
T, Iwasaki Y, Saito K, Hosoya Y, Nakajima T and Funata N: High
incidence of microscopic gastrointestinal stromal tumors in the
stomach. Hum Pathol. 37:1527–1535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Casali PG, Jost L, Reichardt P, Schlemmer
M and Blay JY: ESMO Guidelines Working Group: Gastrointestinal
stromal tumours: ESMO clinical recommendations for diagnosis,
treatment and follow-up. Ann Oncol. 20(Suppl 4): 64–67.
2009.PubMed/NCBI
|
|
13
|
Joensuu H: Risk stratification of patients
diagnosed with gastrointestinal stromal tumor. Hum Pathol.
39:1411–1419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Demetri GD, von Mehren M, Antonescu CR,
DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF,
Schuetze S, et al: NCCN Task Force report: Update on the management
of patients with gastrointestinal stromal tumors. J Natl Compr Canc
Netw. 8(Suppl 2): S1–S41. (quiz S42-S44). 2010.PubMed/NCBI
|
|
15
|
Rossi S, Gasparotto D, Toffolatti L,
Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M,
Cantaloni C, Messerini L, et al: Molecular and clinicopathologic
characterization of gastrointestinal stromal tumors (GISTs) of
small size. Am J Surg Pathol. 34:1480–1491. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang YJ, Cheng TY, Sun MS, Yang CS, Chen
JH, Liao WC and Wang HP: Suggested cutoff tumor size for management
of small EUS-suspected gastric gastrointestinal stromal tumors. J
Formos Med Assoc. 111:88–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agaimy A, Wünsch PH, Sobin LH, Lasota J
and Miettinen M: Occurrence of other malignancies in patients with
gastrointestinal stromal tumors. Semin Diagn Pathol. 23:120–129.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YP, Li Y and Song C: Metachronous
multiple gastrointestinal stromal tumors and adenocarcinoma of the
colon: A case report. Oncol Lett. 8:1123–1126. 2014.PubMed/NCBI
|
|
19
|
Agaimy A, Wünsch PH, Dirnhofer S, Bihl MP,
Terracciano LM and Tornillo L: Microscopic gastrointestinal stromal
tumors in esophageal and intestinal surgical resection specimens: A
clinicopathologic, immunohistochemical, and molecular study of 19
lesions. Am J Surg Pathol. 32:867–873. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chetty R: Small and microscopically
detected gastrointestinal stromal tumours: An overview. Pathology.
40:9–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abraham SC, Krasinskas AM, Hofstetter WL,
Swisher SG and Wu TT: ‘Seedling’ mesenchymal tumors
(gastrointestinal stromal tumors and leiomyomas) are common
incidental tumors of the esophagogastric junction. Am J Surg
Pathol. 31:1629–1635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He YL: Consensus and controversy of
surgical diagnosis and treatment for gastrointestinal stromal
tumor. Zhonghua Wei Chang Wai Ke Za Zhi. 16:201–203. 2013.(In
Chinese). PubMed/NCBI
|
|
23
|
Dematteo RP, Gold JS, Saran L, Gönen M,
Liau KH, Maki RG, Singer S, Besmer P, Brennan MF and Antonescu CR:
Tumor mitotic rate, size and location independently predict
recurrence after resection of primary gastrointestinal stromal
tumor (GIST). Cancer. 112:608–615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Feng F, Li M, Sun L, Hong L, Cai
L, Wang W, Xu G and Zhang H: Surgical resection should be taken
into consideration for the treatment of small gastric
gastrointestinal stromal tumors. World J Surg Oncol. 11:2732013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim MY, Park YS, Choi KD, Lee JH, Choi KS,
Kim H, Song HJ, Lee GH, Jung HY, Kim JH, et al: Predictors of
recurrence after resection of small gastric gastrointestinal
stromal tumors of 5 cm or less. J Clin Gastroenterol. 46:130–137.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Corless CL, McGreevey L, Haley A, Town A
and Heinrich MC: KIT mutations are common in incidental
gastrointestinal stromal tumors one centimeter or less in size. Am
J Pathol. 160:1567–1572. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Vogelaere K, Van Loo I, Peters O,
Hoorens A, Haentjens P and Delvaux G: Laparoscopic resection of
gastric gastrointestinal stromal tumors (GIST) is safe and
effective, irrespective of tumor size. Surg Endosc. 26:2339–2345.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miettinen M, Furlong M, Sarlomo-Rikala M,
Burke A, Sobin LH and Lasota J: Gastrointestinal stromal tumors,
intramural leiomyomas, and leiomyosarcomas in the rectum and anus:
A clinicopathologic, immunohistochemical, and molecular genetic
study of 144 cases. Am J Surg Pathol. 25:1121–1133. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun LF, He JJ, Yu SJ, Xu JH, Wang JW, Li
J, Song YM, Ding KF and Zheng S: Transsacral excision with
pre-operative imatinib mesylate treatment and approach for
gastrointestinal stromal tumors in the rectum: A report of two
cases. Oncol Lett. 8:1455–1460. 2014.PubMed/NCBI
|
|
30
|
Wilkinson MJ, Fitzgerald JE, Strauss DC,
Hayes AJ, Thomas JM, Messiou C, Fisher C, Benson C, Tekkis PP and
Judson I: Surgical treatment of gastrointestinal stromal tumour of
the rectum in the era of imatinib. Br J Surg. 102:965–971. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu H, Yan Z, Liao G and Yin H: Treatment
strategy of rectal gastrointestinal stromal tumor (GIST). J Surg
Oncol. 109:708–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang JP, Wang T, Huang MJ, Wang L, Kang L
and Wu XJ: The role of neoadjuvant imatinib mesylate therapy in
sphincter-preserving procedures for anorectal gastrointestinal
stromal tumor. Am J Clin Oncol. 34:314–316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong C, Jun-Hui C, Xiao-Jun Y, Mei K, Bo
W, Chen-Fe J and Wei-Li Y: Gastrointestinal stromal tumors of the
rectum: Clinical, pathologic, immunohistochemical characteristics
and prognostic analysis. Scand J Gastroenterol. 42:1221–1229. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen BX, Hao DM and Zhang ZX: Prognostic
analysis of 40 cases with rectal gastrointestinal stromal tumor.
Zhonghua Wei Chang Wai Ke Za Zhi. 15:263–265. 2012.(In Chinese).
PubMed/NCBI
|
|
35
|
Pathmanathan N and Balleine RL: Ki67 and
proliferation in breast cancer. J Clin Pathol. 66:512–516. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Koumarianou A, Chatzellis E, Boutzios G,
Tsavaris N and Kaltsas G: Current concepts in the diagnosis and
management of poorly differentiated gastrointestinal neuroendocrine
carcinomas. Endokrynol Pol. 64:60–72. 2013.PubMed/NCBI
|
|
37
|
Zhao WY, Xu J, Wang M, Zhang ZZ, Tu L,
Wang CJ, Lin TL, Shen YY, Liu Q and Cao H: Prognostic value of Ki67
index in gastrointestinal stromal tumors. Int J Clin Exp Pathol.
7:2298–2304. 2014.PubMed/NCBI
|
|
38
|
Wang H, Chen P, Liu XX, Zhao W, Shi L, Gu
XW, Zhu CR, Zhu HH and Zong L: Prognostic impact of
gastrointestinal bleeding and expression of PTEN and Ki-67 on
primary gastrointestinal stromal tumors. World J Surg Oncol.
12:892014. View Article : Google Scholar : PubMed/NCBI
|
